Neuroone Medical Technologies Corp (NMTC)

Currency in USD
0.745
+0.015(+1.99%)
Real-time Data·
NMTC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.7100.747
52 wk Range
0.5001.160
Key Statistics
Prev. Close
0.73
Open
0.71
Day's Range
0.71-0.747
52 wk Range
0.5-1.16
Volume
210.9K
Average Vol. (3m)
220.64K
1-Year Change
37.4074%
Book Value / Share
0.13
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NMTC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.033
Upside
+172.93%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company is based in Eden Prairie, Minnesota.

Neuroone Medical Technologies Corp Earnings Call Summary for Q1/2026

  • NeuroOne Medical reported Q1 Fiscal 2026 net loss of $1.4M ($0.03 per share), beating EPS forecast of -$0.04; revenue reached $2.9M, slightly exceeding $2.86M forecast.
  • Despite positive earnings results, stock declined 1.11% in premarket trading; revenue fell year-over-year but increased 5.5% sequentially from Q4 Fiscal 2025.
  • Product gross profit reached $1.6M (54.2% of revenue); CEO Dave Rosa noted ablations performed in Q1 2026 represented nearly half of all ablations since launch.
  • Management projects minimum 17% revenue growth for Fiscal 2026, driven by product development, strategic partnerships, and international market expansion.
  • CFO Ron McClurg cautioned that R&D expenses may fluctuate depending on project phases; analysts expressed concerns about revenue composition and growth sustainability.
Last Updated: 02/17/2026, 09:05 AM
Read Full Transcript

Compare NMTC to Peers and Sector

Metrics to compare
NMTC
Peers
Sector
Relationship
P/E Ratio
−5.5x−3.8x−0.5x
PEG Ratio
−0.14−0.040.00
Price / Book
5.9x4.4x2.6x
Price / LTM Sales
3.2x3.0x3.2x
Upside (Analyst Target)
119.2%35.7%47.6%
Fair Value Upside
Unlock4.2%6.1%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2.033
(+172.93% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Jones Trading
Buy1.50+102.16%-New CoverageMar 02, 2026
Maxim Group
Buy3.00+304.31%-New CoverageSep 09, 2025
Ladenburg Thalmann
Buy1.45+95.42%-New CoverageMay 05, 2025

Earnings

Latest Release
Feb 17, 2026
EPS / Forecast
-0.03 / -0.04
Revenue / Forecast
2.89M / 2.86M
EPS Revisions
Last 90 days

NMTC Income Statement

People Also Watch

1.155
RXT
-6.85%
3.310
ELDN
+3.44%
35.68
FLY
-2.54%
18.29
KVYO
+7.97%

FAQ

What Is the Neuroone Medical (NMTC) Stock Price Today?

The Neuroone Medical stock price today is 0.745 USD.

What Stock Exchange Does Neuroone Medical Trade On?

Neuroone Medical is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Neuroone Medical?

The stock symbol for Neuroone Medical is "NMTC."

What Is the Neuroone Medical Market Cap?

As of today, Neuroone Medical market cap is 37.610M USD.

What Is Neuroone Medical's Earnings Per Share (TTM)?

The Neuroone Medical EPS (TTM) is -0.155.

When Is the Next Neuroone Medical Earnings Date?

Neuroone Medical will release its next earnings report on May 07, 2026.

From a Technical Analysis Perspective, Is NMTC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Neuroone Medical Stock Split?

Neuroone Medical has split 2 times.

How Many Employees Does Neuroone Medical Have?

Neuroone Medical has 18 employees.

What is the current trading status of Neuroone Medical (NMTC)?

As of Apr 15, 2026, Neuroone Medical (NMTC) is trading at a price of 0.745 USD, with a previous close of 0.730 USD. The stock has fluctuated within a day range of 0.710 USD to 0.747 USD, while its 52-week range spans from 0.500 USD to 1.160 USD.

What Is Neuroone Medical (NMTC) Price Target According to Analysts?

The average 12-month price target for Neuroone Medical is 2.033 USD, with a high estimate of 3 USD and a low estimate of 1.5 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +172.93% Upside potential.

What Is the NMTC Premarket Price?

NMTC's last pre-market stock price is 0.745 USD. The pre-market share volume is 6,420.000, and the stock has decreased by 0.015, or 2.000%.

What Is the NMTC After Hours Price?

NMTC's last after hours stock price is 0.728 USD, the stock has decreased by -0.002, or -0.270%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.